ABL Bio Inc. (298380.KQ)

KRW 64700.0

(-0.31%)

Operating Expenses Summary of ABL Bio Inc.

ABL Bio Inc.'s latest annual operating expenses in 2023 was 65.52 Billion KRW , down -1.51% from previous year.
ABL Bio Inc.'s latest quarterly operating expenses in 2024 Q1 was 15.95 Billion KRW , up 43.18% from previous quarter.
ABL Bio Inc. reported a annual operating expenses of 44.65 Billion KRW in annual operating expenses 2022, up 48.91% from previous year.
ABL Bio Inc. reported a annual operating expenses of 29.98 Billion KRW in annual operating expenses 2021, down -48.15% from previous year.
ABL Bio Inc. reported a quarterly operating expenses of 15.83 Billion KRW for 2024 Q2, down -0.78% from previous quarter.
ABL Bio Inc. reported a quarterly operating expenses of 43.97 Billion KRW for 2023 FY, down -1.51% from previous quarter.

Annual Operating Expenses Chart of ABL Bio Inc. (2023 - 2016)

Historical Annual Operating Expenses of ABL Bio Inc. (2023 - 2016)

Year	Operating Expenses	Operating Expenses Growth
2023	65.52 Billion KRW	-1.51%
2022	44.65 Billion KRW	48.91%
2021	29.98 Billion KRW	-48.15%
2020	57.83 Billion KRW	62.84%
2019	35.51 Billion KRW	62.97%
2018	21.79 Billion KRW	172.24%
2017	8 Billion KRW	139.65%
2016	3.34 Billion KRW	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q1	15.95 Billion KRW	43.18%
2024 Q2	15.83 Billion KRW	-0.78%
2023 FY	43.97 Billion KRW	-1.51%
2023 Q4	11.14 Billion KRW	39.32%
2023 Q3	7.99 Billion KRW	-39.68%
2023 Q2	13.26 Billion KRW	14.55%
2023 Q1	11.57 Billion KRW	-17.6%
2022 Q1	10.92 Billion KRW	-19.35%
2022 FY	44.65 Billion KRW	48.91%
2022 Q4	14.04 Billion KRW	60.97%
2022 Q3	8.72 Billion KRW	-34.24%
2022 Q2	13.27 Billion KRW	21.5%
2021 Q3	9.72 Billion KRW	-14.75%
2021 Q2	11.4 Billion KRW	8.88%
2021 Q4	13.54 Billion KRW	39.3%
2021 Q1	10.47 Billion KRW	0.0%
2021 FY	29.98 Billion KRW	-48.15%
2020 FY	57.83 Billion KRW	62.84%
2019 FY	35.51 Billion KRW	62.97%
2018 FY	21.79 Billion KRW	172.24%
2017 FY	8 Billion KRW	139.65%
2016 FY	3.34 Billion KRW	0.0%

Peer Operating Expenses Comparison of ABL Bio Inc.

Name	Operating Expenses	Operating Expenses Difference
Sam Chun Dang Pharm. Co., Ltd	84.83 Billion KRW	22.76%
Hyundai Bioscience Co., Ltd.	14.82 Billion KRW	-341.971%
ST Pharm Co.,Ltd.	75.59 Billion KRW	13.315%
Cellid, Co., Ltd.	10.97 Billion KRW	-497.038%